Seres Therapeutics MCRB
NASDAQ MCRB
$2.30 -0.01 (-0.43%)
At close: Oct 21, 2026 · 4:00 PM EDT

Seres Therapeutics (MCRB) Interest Coverage Ratio (2020 - 2024)

Updated

Seres Therapeutics' (MCRB) Interest Coverage Ratio came in at -55.72 for Q1 2024, compared with -36.23 a year earlier.

Analysis

Seres Therapeutics (MCRB) Interest Coverage Ratio (2020 - 2024) Analysis & Trends

For FY2023, Seres Therapeutics' Interest Coverage Ratio stood at -79.05.

  • In prior years, Seres Therapeutics' Interest Coverage Ratio was -29.89 in FY2022, -22.16 in FY2021, -30.14 in FY2020 and -143.18 in FY2019.
  • The Q1 2024 figure stands as the lowest quarterly Interest Coverage Ratio since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Seres Therapeutics 22.42 Mn -116.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -55.72
Jun 30, 2023 15.54
Mar 31, 2023 -36.23
Dec 31, 2022 -0.92
Sep 30, 2022 -34.23
Jun 30, 2022 -42.19
Mar 31, 2022 -61.13
Dec 31, 2021 -66.98
Sep 30, 2021 91.94
Jun 30, 2021 -65.77
Mar 31, 2021 -50.76
Dec 31, 2020 -23.58
Sep 30, 2020 -41.09
Jun 30, 2020 -28.57
Mar 31, 2020 -27.50
API Access

Seres Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=MCRB&period=max&api_key=YOUR_API_KEY